search

Open main menu menu

Close main menu close

Main menu

Channels
- Asia Pacific
- Brexit
- Deals
- Fixed Income
- Managers
- Outsourcing
- People
- Real Assets
- Regulation
- Risk
- SAA/ALM
- SFCR
- Sustainability
- Systems/Data
- Tax/Accounting
- USA Focus
Events
Awards
Market Insight
Spotlight
Webinars

Sign-in Register

Home
Archive

Archive

AXA IM Alts invests CHF 14m in vaccine developer

09 October 2023

Equity investment in LimmaTech will help develop vaccines to pathogens linked to antimicrobial resistance

Sections

Awards
Downloads
Events
Galleries
Insight
Investment Grade Private Credit Focus
Market Insight
Roundtables
Spotlight
Sustainable Investing Focus
Webinars
White Papers

Company

About Us
Contact Us
Advertise
Subscriptions
Website Terms & Conditions
Subscription and Event
Terms & Conditions
Privacy Policy
Cookie Policy
Acceptable Use Policy

Channels

Asia Pacific
Brexit
Deals
Fixed Income
Managers
Outsourcing
People
Real Assets
Regulation
Risk
SAA/ALM
SFCR
Sustainability
Systems/Data
Tax/Accounting
USA Focus

Subscriptions

Subscribe to Insurance Asset Risk to benefit from:

article In-depth special reports and analysis

verified Commentary and insight from leading industry specialists

sell Discounts for Insurance Asset Risk events

Subscribe now

© Field Gibson Media Ltd 2024